Linagliptin — part of our diabetes & metabolic range within JackRabbit's pharmaceutical export portfolio. SGLT2 inhibitors, DPP-4 inhibitors and first-line biguanides for type 2 diabetes management — 7 molecules including Metformin, Empagliflozin and Sitagliptin.
Linagliptin is supplied through JackRabbit's pharmaceutical export division, within our diabetes & metabolic category. SGLT2 inhibitors, DPP-4 inhibitors and first-line biguanides for type 2 diabetes management — 7 molecules including Metformin, Empagliflozin and Sitagliptin.
As with every molecule in our catalogue, Linagliptin is sourced from a vetted, GMP-certified Indian manufacturer, with documentation matched to your destination market's regulatory requirements. Share your target quantity and specification and our team will confirm availability and pricing within 24 hours.
Sourced from a WHO-GMP audited Indian manufacturer
Full documentation provided with every shipment
Sample & trial orders available
Can be consolidated with other sectors in one shipment
Patent Notice: Molecules under patent are offered subject to the patent laws of the importing country. The buyer is solely responsible for confirming patent status and compliance in the destination market.
Share your target quantity, destination market and any specification requirements. Our team responds within 24 hours with pricing and availability.